PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34662587-4	2021	FLG nanodrugs were constructed by connecting VEGF/VEGFR2 inhibitory low molecular weight heparin and gambogic acid with F3 peptide decoration for directly regulating on vascular endothelial cells and inducing vascular normalization.	gambogic acid	101-114	vascular endothelial growth factor A	Homo sapiens	45-49	
28901512-7	2017	Treatment with gambogic acid suppressed the activities of interleukin (IL)-1beta and IL-6, promoted the protein expression of phosphorylated (p)-Akt serine/threonine kinase (Akt), p-mammalian target protein of rapamycin (mTOR) and inhibited hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in RA rats.	gambogic acid	15-28	vascular endothelial growth factor A	Homo sapiens	277-311	
24890366-0	2014	Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1alpha/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells.	gambogic acid	0-13	vascular endothelial growth factor A	Homo sapiens	73-107	
23047550-11	2012	In addition, gambogic acid suppressed the VEGFA-induced PDGFRbeta tyrosine phosphorylation.	gambogic acid	13-26	vascular endothelial growth factor A	Homo sapiens	42-47	
17920764-0	2007	Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1.	gambogic acid	0-13	vascular endothelial growth factor A	Homo sapiens	56-90	
17920764-3	2007	GA inhibits the VEGF-stimulated proliferation, migration and tube formation of human umbilical vein endothelial cells (HUVECs) as well as microvessel sprouting from rat aortic rings in vitro.	gambogic acid	0-2	vascular endothelial growth factor A	Homo sapiens	16-20	
17920764-5	2007	The results also indicated that GA decreases VEGF production of cultured tumor cells and inhibits VEGF-induced tyrosine phosphorylation of KDR/Flk-1.	gambogic acid	32-34	vascular endothelial growth factor A	Homo sapiens	45-49	
17920764-5	2007	The results also indicated that GA decreases VEGF production of cultured tumor cells and inhibits VEGF-induced tyrosine phosphorylation of KDR/Flk-1.	gambogic acid	32-34	vascular endothelial growth factor A	Homo sapiens	98-102